Collaborative Approach
When it comes to partnering, Pfizer brings a mix of transparency and flexibility to each deal to ensure successful interactions over the long term. As our partner, you'll be part of a team that works together to turn today's discoveries into tomorrow's breakthroughs.
We believe in building trust from our very first interactions—regardless of the size of the deal. Experienced alliance managers will work with your team every step of the way, with open communication at all levels to ensure the application of appropriate resources. Our combined talent and expertise is brought to bear in order to ensure that effective governance and shared decision making is applied to each allied development program.
Adolor can say that, from the people with whom we have been working on a day-to-day basis, to the very top of the Company, we have been nothing short of overwhelmed with the energy that has gone into putting this collaboration together, and believe that Pfizer is highly motivated to present themselves as a partner of choice.
—Kevin Taylor, Vice President of Business Development, Adolor Corporation
We understand that each partnership opportunity is unique. And, we are open to varying deal and financial structures. From licensing agreements, co-promotion and co-development deals, to acquisitions and beyond, we will work with you to develop a deal that meets both our needs.
Pfizer clearly stood out from the competition by their responsiveness and flexibility in negotiations and interactions. The negotiation process was carried out professionally with a positive spirit and time set aside for solving differences...My overall impression of Pfizer, based on the people I interacted with, is that Pfizer is a highly professional company that is willing to listen and keeps its promise.
—Weishui Weiser, Managing Director, Scil Technology GmbH
We're serious about our commitment to you and your compound or technology. We work hard to earn our collaborators' trust and respect, by building open communication and shared goals. And we treat your discovery as if it were our own.
The negotiations were conducted in a friendly atmosphere with a genuine effort to persevere and creatively overcome the difficulties. We were particularly impressed with Pfizer's teamwork, the excellence and the professionalism with which all team members, regardless of seniority, contributed to the overall endeavor...We at Quark feel that we entrusted our potential drug in the hands of a company that will nurture it and take it in the best possible way down the torturous route of drug development. At the same time, we are confident that Pfizer will continue to treat us as a real partner in overcoming the challenges that lie ahead.
—Daniel Zurr, Chief Executive Officer, Quark
The Adolor/Pfizer collaboration has the fundamental building blocks of a solid, mutually beneficial alliance. In any collaboration, organizational differences—combined with the day-to-day challenges of drug development—make for a potentially challenging relationship. However, both Adolor and Pfizer have worked hard from the start to ensure that honest discussion and shared decision making is at the core of their work. Through the development of joint steering committees, team-building exercises, face-to-face meetings, and clearly defined roles and responsibilities, they've formed a strong collaboration that will continue to strengthen even further over time.
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2010 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
